98 Results for "

ion channel selectivity

" in MedChemExpress (MCE) Product Catalog:
Products (98)

98 Results for "ion channel selectivity" in MCE Product Catalog:

49
49 Publications Verification
Cat. No.: HY-15084B
CAS No.: 77086-21-6
Purity:  99.90%
Synonyms: MK-801
Target:  

iGluR

Research Areas:  

Neurological Disease

Dizocilpine (MK-801), a potent anticonvulsant, is a selective and non-competitive NMDA receptor antagonist, with a Kd of 37.2 nM in rat brain membranes. Dizocilpine acts by binding to a site located within the NMDA associated ion channel and thus prevents Ca 2+ flux .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-B1221
CAS No.: 530-78-9
Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca 2+ channels, modulating non-selective cation channels (NSC), activating K + channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-19765
CAS No.: 1419609-94-1
Target:  

TRP Channel

Research Areas:  

Cardiovascular Disease

GSK2798745 is a potent, selective, and orally active transient receptor potential vanilloid 4 (TRPV4) ion channel blocker with IC50s of 1.8 and 1.6 nM for hTRPV4 and rTRPV4, respectively. GSK2798745 can be used in cardiac and respiratory diseases research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15568
CAS No.: 475205-49-3
Purity:  98.64%
A-317491 is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15568A
Purity:  99.88%
A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 sodium salt hydrate is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 sodium salt hydrate reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-130605
CAS No.: 2055602-83-8
Purity:  99.76%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

BAY-1797, a chemical probe, is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15419
CAS No.: 199864-86-3
Purity:  99.78%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12501A
CAS No.: 1642303-38-5
Purity:  99.19%
Research Areas:  

Neurological Disease

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 shows efficacy in various animal models of motor and cognitive functions .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0023
CAS No.: 123524-52-7
Synonyms: CS 905
Azelnidipine (CS 905) is a dihydropyridine calcium channel blocker that is effective orally. Azelnidipine inhibits the intracellular calcium ion flow and lower blood pressure by selectively blocking L-type calcium channel on the membrane of vascular smooth muscle. Azelnidipine inhibits esophageal squamous cell carcinoma proliferation by targeting MEK1/2. Azelnidipine also has anti-inflammatory, antioxidant and neuroprotective effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15419A
CAS No.: 199864-87-4
Purity:  99.62%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS-127445 is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0190
CAS No.: 129203-60-7
Iberiotoxin is a toxin isolated from Buthus tamulus scorpion venom. Iberiotoxin is a selective high conductance high conductance Ca 2+-activated K + channel inhibitor with a Kd of ~1 nM. Iberiotoxin does not block other types of voltage-dependent ion channels .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134494
CAS No.: 2375070-79-2
Purity:  99.90%
Target:  

GPR68

Research Areas:  

Neurological Disease

MS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). MS48107 is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. MS48107 can readily cross the blood-brain barrier (BBB) in mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-107625A
CAS No.: 1781934-47-1
Purity:  99.90%
Target:  

MCHR1 (GPR24)

Research Areas:  

Neurological Disease

SNAP 94847 hydrochloride is a novel, high affinity selective melanin-concentrating hormonereceptor1 (MCHR1) antagonist with (Ki= 2.2 nM, Kd=530 pM), it displays >80-fold and >500-fold selectivity over MCHα1A and MCHD2 receptors respectively. SNAP 94847 hydrochloride binds with high affinity to the mouse and rat MCHR1 with minimal cross-reactivity to other GPCR, ion channels, enzymes, and transporters .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0190A
Target:  

Potassium Channel

Research Areas:  

Others

Iberiotoxin (TFA) is a selective high conductance high conductance Ca 2+-activated K + channel inhibitor with a Kd of ~1 nM. Iberiotoxin (TFA) does not block other types of voltage-dependent ion channels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139791
CAS No.: 1009344-33-5
Purity:  99.61%
Synonyms: XEN1101
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Azetukalner (XEN1101) is a selective and orally active Kv7.2/Kv7.3 potassium channel opener with an EC50 of 27 nM. Azetukalner is approximately 4-fold more selective for Kv7.2/7.3 over Kv7.3/7.5 (EC50 of 94 nM) and Kv7.4 (EC50 of 113 nM) channels. Azetukalner exhibits a selectivity >100-fold for Kv7 channels over other ion channels and receptors. Azetukalner can be used for the study of focal epilepsy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17436
CAS No.: 167221-71-8
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease Cancer

Clevidipine is a selective, short-acting L-type calcium channel antagonist with an IC50 of 7.1 nM. Clevidipine can competitively bind to calcium channels and exert rapid vasoselective vasodilation by blocking the influx of extracellular calcium ions, thereby reducing peripheral vascular resistance and effectively controlling acute severe hypertension. Clevidipine can also protect the myocardium from reperfusion injury by promoting the release of nitric oxide (NO). Clevidipine can be used in the research of acute hypertension, perioperative blood pressure management, and myocardial ischemia-reperfusion injury .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N8264
CAS No.: 73255-40-0
Moringin is a potent and selective TRPA1 ion channel natural agonist with an EC50 of 3.14 μM. Moringin does not activate or activates very weakly the vanilloids somatosensory channels TRPV1, TRPV2, TRPV3 and TRPV4, and the melastatin cooling receptor TRPM8. Moringin has hypoglycemic, antimicrobial, anti-inflammatory, anticancer and neuroprotection activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19838
CAS No.: 1802326-66-4
Target:  

GPR139

Research Areas:  

Neurological Disease

JNJ-63533054 is a potent, selective and orally active GPR139 agonist with an EC50 of 16 nM for human GPR139 (hGPR139). JNJ-63533054 shows selective for GPR139 over other GPCRs, ion channels, and transporters. JNJ-63533054 can cross the blood-brain barrier (BBB) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0082
CAS No.: 3254-89-5
Synonyms: Difenidol hydrochloride
Target:  

mAChR Sodium Channel

Research Areas:  

Neurological Disease

Diphenidol hydrochloride (Difenidol hydrochloride) is a non-selective muscarinic M1-M4 receptor antagonist, has anti-arrhythmic activity. Diphenidol hydrochloride is also a potent non-specific blocker of voltage-gated ion channels (Na +, K +, and Ca 2+) in neuronal cells. Diphenidol hydrochloride can be used in the study of antivertigo and antinausea .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111866
CAS No.: 1801547-16-9
Purity:  99.89%
Target:  

PROTACs RIP kinase

Research Areas:  

Metabolic Disease

PROTAC RIPK degraders -2 is a non-peptide PROTAC based on von Hippel-Lindau and targets serine-threonine kinase RIPK2, which is highly selective to the degradation of RIPK2. PROTAC RIPK degrader-2 acts as an activator to increase cell death and activate ion channels in cancer cells. PROTAC RIPK degrader-2 also can inhibit protein interactions, such as receptors and ligands, involved in a variety of diseases, such as cancer and diabetes .
loading...
    loading...